These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17614878)

  • 21. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents.
    Ward SG; Finan P
    Curr Opin Pharmacol; 2003 Aug; 3(4):426-34. PubMed ID: 12901953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of PI-3 kinase for treating respiratory disease: good idea or bad idea?
    Thomas M; Owen C
    Curr Opin Pharmacol; 2008 Jun; 8(3):267-74. PubMed ID: 18394961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ncRNA-regulated immune response and its role in inflammatory lung diseases.
    Xie N; Liu G
    Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1076-87. PubMed ID: 26432871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models.
    Winkler DG; Faia KL; DiNitto JP; Ali JA; White KF; Brophy EE; Pink MM; Proctor JL; Lussier J; Martin CM; Hoyt JG; Tillotson B; Murphy EL; Lim AR; Thomas BD; Macdougall JR; Ren P; Liu Y; Li LS; Jessen KA; Fritz CC; Dunbar JL; Porter JR; Rommel C; Palombella VJ; Changelian PS; Kutok JL
    Chem Biol; 2013 Nov; 20(11):1364-74. PubMed ID: 24211136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K).
    Mishra RK; Scaife JE; Harb Z; Gray BC; Djukanovic R; Dent G
    Allergy; 2005 Sep; 60(9):1204-7. PubMed ID: 16076309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphoinositide 3-kinase delta (PI3Kδ) in leukocyte signaling and function.
    Fung-Leung WP
    Cell Signal; 2011 Apr; 23(4):603-8. PubMed ID: 20940048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases.
    Sriskantharajah S; Hamblin N; Worsley S; Calver AR; Hessel EM; Amour A
    Ann N Y Acad Sci; 2013 Mar; 1280():35-9. PubMed ID: 23551101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of PI3K Isoforms in Autoimmune Disease.
    Ward SG
    Curr Top Microbiol Immunol; 2022; 436():337-347. PubMed ID: 36243851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?
    Fougerat A; Gayral S; Malet N; Briand-Mesange F; Breton-Douillon M; Laffargue M
    Clin Sci (Lond); 2009 May; 116(11):791-804. PubMed ID: 19397491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The phosphoinositide-3 kinase survival signaling mechanism in sepsis.
    Manukyan MC; Weil BR; Wang Y; Abarbanell AM; Herrmann JL; Poynter JA; Meldrum DR
    Shock; 2010 Nov; 34(5):442-9. PubMed ID: 20386497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 7. Immunologic lung disease.
    Greenberger PA
    J Allergy Clin Immunol; 2008 Feb; 121(2 Suppl):S393-7; quiz S418. PubMed ID: 18241689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.
    Ito K; Caramori G; Adcock IM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):1-8. PubMed ID: 17021257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteinase-activated receptors in fibroproliferative lung disease.
    José RJ; Williams AE; Chambers RC
    Thorax; 2014 Feb; 69(2):190-2. PubMed ID: 24186921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immune recognition in infectious and noninfectious diseases of the lung.
    Opitz B; van Laak V; Eitel J; Suttorp N
    Am J Respir Crit Care Med; 2010 Jun; 181(12):1294-309. PubMed ID: 20167850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sat-Nav for T cells: Role of PI3K isoforms and lipid phosphatases in migration of T lymphocytes.
    Ward SG; Westwick J; Harris S
    Immunol Lett; 2011 Jul; 138(1):15-8. PubMed ID: 21333676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter?
    Baer R; Cintas C; Therville N; Guillermet-Guibert J
    Adv Biol Regul; 2015 Sep; 59():19-35. PubMed ID: 26166735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The phosphoinositide 3'-kinase p110δ modulates contractile protein production and IL-6 release in human airway smooth muscle.
    Ge Q; Moir LM; Trian T; Niimi K; Poniris M; Shepherd PR; Black JL; Oliver BG; Burgess JK
    J Cell Physiol; 2012 Aug; 227(8):3044-52. PubMed ID: 22015454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphoinositide 3-kinase: diverse roles in immune cell activation.
    Deane JA; Fruman DA
    Annu Rev Immunol; 2004; 22():563-98. PubMed ID: 15032589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemical biology of phosphoinositide 3-kinases.
    Wymann MP; Schultz C
    Chembiochem; 2012 Sep; 13(14):2022-35. PubMed ID: 22965647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphoinositide 3-Kinase in Asthma: Novel Roles and Therapeutic Approaches.
    Yoo EJ; Ojiaku CA; Sunder K; Panettieri RA
    Am J Respir Cell Mol Biol; 2017 Jun; 56(6):700-707. PubMed ID: 27977296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.